M-Phenoxybenzoic Acid For Cis-Isomer

M-Phenoxybenzoic Acid For Cis-Isomer

SCHEMBL128732

O=C(O)c1cccc(Oc2ccccc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 1.00
KMO O15229 1/20 0.69
HDAC8 Q9BY41 1/20 0.68
KDM4E B2RXH2 1/20 0.68
NPC1 O15118 2/20 0.63
POLB P06746 1/20 0.62
CYP2C9 P11712 1/20 0.62
RAB9A P51151 1/20 0.62
ERCC5 P28715 1/20 0.62
FEN1 P39748 1/20 0.62
NR1H4 Q96RI1 1/20 0.61
NR4A2 P43354 1/20 0.61
SRD5A2 P31213 1/20 0.60
PKM P14618 1/20 0.59
TNKS O95271 1/20 0.59
PARP15 Q460N3 1/20 0.59
PARP14 Q460N5 1/20 0.59
PARP10 Q53GL7 1/20 0.59
TNKS2 Q9H2K2 1/20 0.59
PARP2 Q9UGN5 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
M-Phenoxybenzoic Acid For Cis-Isomer SCHEMBL30445868 1.00 AKR1C3 (1.00) AKR1C3KMOHDAC8KDM4ENPC1
M-Phenoxybenzoic Acid For Cis-Isomer SCHEMBL29522837 1.00 AKR1C3 (1.00) AKR1C3KMOHDAC8KDM4ENPC1
SCHEMBL28701196 0.98 AKR1C3 (0.96) AKR1C3KMOHDAC8KDM4ENPC1
SCHEMBL4320685 0.98 AKR1C3 (0.96) AKR1C3KMOHDAC8KDM4ENPC1
SCHEMBL29546656 0.98 AKR1C3 (0.96) AKR1C3KMOHDAC8KDM4ENPC1
M-Phenoxybenzoic Acid For Cis-Isomer SCHEMBL11419399 0.98 AKR1C3 (0.96) AKR1C3KMOHDAC8KDM4ENPC1
SCHEMBL1042631 0.96 AKR1C3 (0.92) AKR1C3KMOHDAC8KDM4ENPC1
SCHEMBL30266789 0.96 AKR1C3 (0.92) AKR1C3KMOHDAC8KDM4ENPC1
SCHEMBL68858 0.96 AKR1C3 (0.92) AKR1C3KMOHDAC8KDM4ENPC1
SCHEMBL30449599 0.96 AKR1C3 (0.92) AKR1C3KMOHDAC8KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1503 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600741-B2 3-phenoxybenzoic acid-glucuronic acid conjugate, and preparation method and use thereof SHANXI MEDICAL UNIVERSITY (CN) 2026-04-14 US claimed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
WO-2025202864-A1 ENT1 INHIBITORS IN COMBINATION WITH ONCOLYTIC VIRUSES AND THEIR USE IN THE TREATMENT OF CANCER iTeos Belgium SA (BE) 2025-10-02 WO claimed
WO-2025126110-A1 ENT1 INHIBITORS IN COMBINATION WITH BISPECIFIC ANTIBODIES iTeos Belgium SA (BE) 2025-06-19 WO claimed
WO-2025104613-A1 ENT1 INHIBITORS IN COMBINATION WITH CHECKPOINT INHIBITORS iTeos Belgium SA (BE) 2025-05-22 WO claimed
US-12304977-B2 Polymer, monomer, coating composition comprising same, organic light emitting device using same, and method for manufacturing organic light emitting device by using same LG CHEM, LTD. (KR) 2025-05-20 US claimed
CN-119799320-A Organic narrow-band afterglow material based on halation benzene derivative and preparation and application methods thereof 中国科学院上海有机化学研究所 2025-04-11 CN claimed
CN-116478443-B Preparation method and application of multifunctional molecularly imprinted polymer for detecting various pyrethroid pesticides 西南大学 2025-03-14 CN claimed
CN-119552779-A Bacillus cereus and application thereof 福州大学 2025-03-04 CN claimed
US-20240287119-A1 3-PHENOXYBENZOIC ACID-GLUCURONIC ACID CONJUGATE, AND PREPARATION METHOD AND USE THEREOF SHANXI MEDICAL UNIVERSITY (CN) 2024-08-29 US claimed
WO-1990010450-A1 MONOCLONAL ANTIBODIES TO SYNTHETIC PYRETHROIDS AND METHOD FOR DETECTING THE SAME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1990-09-20 WO claimed
US-4950799-A VANADIUM CATALYST ETHYL CORPORATION (US) 1990-08-21 US claimed
US-4874846-A Process for the preparation of aryloxybenzoic acids containing a sulfonamide group RHONE-POULENC AGROCHIMIE S.A. (FR) 1989-10-17 US claimed
EP-0327163-A2 Detection of chemicals by immunoassay BIOCODE, INC. (US) 1989-08-09 EP claimed
EP-0312571-A1 PROCESS FOR PREPARING POLYKETONES EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1989-04-26 EP claimed
US-4820794-A FROM DICARBOXYLIC ACID AND AROMATIC COMPOUND EASTMAN KODAK COMPANY (US) 1989-04-11 US claimed
WO-1988008010-A1 PROCESS FOR PREPARING POLYKETONES EASTMAN KODAK COMPANY (US) 1988-10-20 WO claimed
US-4314070-A REACTING ALKALI PHENATE WITH ALKYL META-HALOBENZOATE, COPPER SULFATE CATALYST RHONE-POULENC INC. (US) 1982-02-02 US claimed
EP-0021868-B1 PROCESS FOR THE PREPARATION OF DIARYL ETHERS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1981-12-23 EP claimed
EP-0021868-A1 Process for the preparation of diaryl ethers RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1981-01-07 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12304977-B2 Polymer, monomer, coating composition comprising same, organic light emitting device using same, and method for manufacturing organic light emitting device by using same NOTUM, PER2, FTO AKR1C3 3890/4885KMO 2177/4885HDAC8 4754/4885
US-20240287119-A1 3-PHENOXYBENZOIC ACID-GLUCURONIC ACID CONJUGATE, AND PREPARATION METHOD AND USE THEREOF GUSB, UGT1A3, CYP3A43 AKR1C3 1228/4885KMO 527/4885HDAC8 3304/4885
US-12600741-B2 3-phenoxybenzoic acid-glucuronic acid conjugate, and preparation method and use thereof CYP2U1, UGT2B7, UGT1A6 AKR1C3 2978/4885KMO 1096/4885HDAC8 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.